---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-23-000050"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:28:40.283922+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Nautilus Biotechnology holds 2023 annual meeting; reelects three Class II directors

## Summary
- Stockholders elected Parag Mallick, Matthew McIlwain, and Farzad Nazem as Class II directors with >92M votes for each.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023 with 108.8M votes for, 299k against.
- Approximately 109.2M shares represented out of 124.9M outstanding as of April 17, 2023.
- No other business items or significant developments reported.

## SEC filing metadata
- accession: 0001808805-23-000050
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/0001808805-23-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/naut-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-23-000050
- JSON: https://secwatch.observer/filing/0001808805-23-000050.json
- Plain text: https://secwatch.observer/filing/0001808805-23-000050.txt

## Key facts
- Shareholder Votes
  Nautilus Biotechnology, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting: Votes For Votes Against Abstentions 108,805,235 299,293 111,677
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/0001808805-23-000050-index.htm
- Shareholder Votes
  Nautilus Biotechnology, Inc. shareholders approved Election of Class II Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The following nominees were elected to serve as Class II directors, each to hold office until the Company’s 2026 annual meeting of stockholders or until his respective successor has been duly elected and qualified: Nominee Votes For Votes Withheld Broker Non-Votes Parag Mallick 94,833,268 717,809 13,665,128 Matthew McIlwain 92,148,474 3,402,603 13,665,128 Farzad Nazem 95,381,887 169,190 13,665,128
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/0001808805-23-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.